Keane Raymond T
SVP General Counsel & CCO at ARIAD PHARMACEUTICALS INC
- Sold, on record
- $2M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jul 18, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARIAD PHARMACEUTICALS INCSVP General Counsel & CCO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedJul 30, 2012 2012
Sold 10,000 shares at $19.00 ($190k)
Keane Raymond T, SVP General Counsel & CCO
Sold 20.3% of holdings ($936k position)39,280 shares left1x usual sizeFiling
- 2 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedAug 15, 2012 +16 days
Sold 10,000 shares at $20.00 ($200k)
Keane Raymond T, SVP General Counsel & CCO
Sold 20.3% of holdings ($986k position)39,280 shares left1x usual sizeFiling
- 3 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedSep 4, 2012 +20 days
Sold 7,780 shares at $21.00 ($163k)
Keane Raymond T, SVP General Counsel & CCO
Sold 19.8% of holdings ($825k position)31,500 shares left0.8x usual sizeFiling
- 4 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedSep 6, 2012 +2 days
Sold 10,000 shares at $22.00 ($220k)
Keane Raymond T, SVP General Counsel & CCO
Sold 24.1% of holdings ($913k position)31,500 shares left1x usual sizeFiling
- 5 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 22, 2013 +197 days
Sold 2,334 shares at $19.46 ($45k)
Keane Raymond T, SVP General Counsel & CCO
Sold 5.7% of holdings ($792k position)38,347 shares left0.2x usual sizeFiling
- 6 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 25, 2013 +3 days
Sold 13,167 shares at $18.87 ($248k)
Keane Raymond T, SVP General Counsel & CCO
Sold 20.4% of holdings ($1.2M position)51,513 shares left1.3x usual sizeFiling
- 7 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedApr 2, 2013 +8 days
Sold 2,583 shares at $18.05 ($47k)
Keane Raymond T, SVP General Counsel & CCO
Sold 4.6% of holdings ($1M position)54,096 shares left0.3x usual sizeFiling
- 8 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedJul 18, 2013 +107 days
Sold 8,000 shares at $19.79 ($158k)
Keane Raymond T, SVP General Counsel & CCO
Sold 11.4% of holdings ($1.4M position)62,096 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2013 | Jul 18, 2013 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 8,000 | $158k | 11.4% | Plan not stated | SEC |
| Apr 2, 2013 | Apr 3, 2013 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 2,583 | $47k | 4.6% | Plan not stated | SEC |
| Mar 25, 2013 | Mar 26, 2013 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 13,167 | $248k | 20.4% | Plan not stated | SEC |
| Mar 22, 2013 | Mar 22, 2013 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 2,334 | $45k | 5.7% | Plan not stated | SEC |
| Sep 6, 2012 | Sep 7, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,000 | $220k | 24.1% | Plan not stated | SEC |
| Sep 4, 2012 | Sep 5, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 7,780 | $163k | 19.8% | Plan not stated | SEC |
| Aug 15, 2012 | Aug 16, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,000 | $200k | 20.3% | Plan not stated | SEC |
| Jul 30, 2012 | Aug 1, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,000 | $190k | 20.3% | Plan not stated | SEC |
| Jul 26, 2012 | Jul 27, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,000 | $180k | 16.9% | Plan not stated | SEC |
| Apr 3, 2012 | Apr 3, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 2,067 | $33k | 4.0% | Plan not stated | SEC |
| Mar 23, 2012 | Mar 26, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,533 | $162k | 18.7% | Plan not stated | SEC |
| Mar 20, 2012 | Mar 21, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 8,400 | $126k | 21.7% | Plan not stated | SEC |
| Feb 14, 2012 | Feb 16, 2012 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 12,500 | $189k | 41.3% | Unusual | SEC |
| May 17, 2010 | May 19, 2010 | ARIAD PHARMACEUTICALS INC | SVP General Counsel & CCO | Form 4 sale | 10,256 | $42k | 100.0% | Unusual | SEC |